Core Laboratories NV (CLB)

Short-term

Turnover ratios

Core Laboratories NV's activity ratios provide insights into how efficiently the company is managing its assets and liabilities.

1. Inventory Turnover: The inventory turnover ratio measures how many times a company sells and replaces its inventory during a period. Core Laboratories NV's inventory turnover ratio has been consistently low, ranging from 0.05 to 7.77 throughout 2024. A low inventory turnover ratio may indicate slow-moving inventory or overstocking.

2. Receivables Turnover: The receivables turnover ratio reflects how efficiently a company collects its receivables from customers. Core Laboratories NV's receivables turnover ratio has also been relatively stable, ranging from 3.85 to 4.09 in 2024. A higher turnover ratio suggests that the company is collecting its receivables quickly.

3. Payables Turnover: The payables turnover ratio indicates how quickly a company pays its suppliers. Core Laboratories NV's payables turnover ratio has shown significant variability, with a sharp increase to 13.36 by December 31, 2024, from lower levels earlier in the year. A higher turnover ratio may suggest that the company is managing its payables effectively.

4. Working Capital Turnover: The working capital turnover ratio measures how efficiently a company is utilizing its working capital to generate sales. Core Laboratories NV's working capital turnover ratio has shown a slight increase from 3.47 to 4.03 during 2024. A higher turnover ratio indicates that the company is effectively using its working capital to support its operations.

Overall, Core Laboratories NV's activity ratios suggest a mixed efficiency in managing its assets and liabilities. The company should further analyze its inventory levels and payables management to ensure optimal efficiency and profitability.

---

Average number of days

Core Laboratories NV's activity ratios show mixed performance over the year.

1. Days of Inventory on Hand (DOH):
- Core Laboratories NV had a significantly high level of inventory on hand throughout the year, with numbers exceeding 6,000 days. However, there was a drastic decrease in DOH from 6,486.80 days in September 2024 to just 46.98 days in December 2024. This sudden drop indicates a more efficient management of inventory towards the end of the year.

2. Days of Sales Outstanding (DSO):
- The company's DSO remained relatively stable around the mid-90s range, indicating that it took around 90-95 days to collect its accounts receivables. This consistency in DSO suggests a steady credit policy and effective management of receivables over the year.

3. Number of Days of Payables:
- Core Laboratories NV's days of payables varied throughout the year, with significant fluctuations from over 3,000 days to around 27 days. Such variations in the number of days of payables suggest changes in the company's payment terms with suppliers or its ability to manage payables efficiently.

Overall, Core Laboratories NV showed improvements in its inventory and payables management towards the end of the year, while maintaining stable accounts receivables turnover throughout the period.

---

Long-term

The Fixed Asset Turnover ratio for Core Laboratories NV has shown a consistent upward trend throughout the year 2024, starting at 5.06 in March and reaching 5.36 by December. This indicates that the company is generating revenue efficiently in relation to its investment in fixed assets, such as property, plant, and equipment.

In comparison, the Total Asset Turnover ratio has also exhibited a gradual increase over the same period, rising from 0.85 in March to 0.88 in December. This metric reflects how well the company utilizes its total assets to generate revenue.

Overall, the increasing trends in both Fixed Asset Turnover and Total Asset Turnover ratios suggest that Core Laboratories NV is effectively managing its asset base to drive revenue growth and maximize operational efficiency.